logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ESMO 2019 — Tailored ipilimumab “boost” increases response to nivolumab in advanced renal cell carcinoma

Study is the first to assess a tailored approach to boosting NIVO treatment with IPI.